| [1] |
Socinski MA, Morris DE, Masters GA, et al. Chemotherapeutic managenment of stage Ⅳ non-small cell lung cancer [J]. Chest,2003,123(1 Suppl):226S-243S.
|
| [2] |
Scagliotti GV, Parikh P, von Pawel J, et al. Phase Ⅲ study comparing cisplatin plus gemcitabine with cisplatin plus pemetrexed in chemotherapy-naive patients with advanced-stage non-small-cell lung cancer[J].J Clin Oncol,2008,26(21):3543-51.
|
| [3] |
Scagliotti G, Hanna N, Fossella F, et al. The differential effi cacy of pemetrexed according to NSCLC histology: a review of two Phase Ⅲ studies[J].Oncologist,2009,14(3): 253-63.
|
| [4] |
Ciuleanu T, Brodowicz T, Zielinski C, et al. Maintenance pemetrexed plus best supportive care versus placebo plus best supportive care for non-small-cell lung cancer: a randomised, double-blind, phase 3 study[J].Lancet,2009,374(9699):1432-40.
|
| [5] |
Fossella F, Pereira JR, von Pawel J, et al. Randomized, multinational, phase Ⅲ study of docetaxel plus platinum combinations versus vinorelbine plus cisplatin for advanced nonsmall- cell lung cancer: the TAX 326 study group[J].J Clin Oncol, 20 03,21(16):3016-24.
|
| [6] |
Jiang L, Wang DY, Zhu ZH, et al. Phase Ⅱ study of carboplatin combined with weekly docetaxel in patients with advanced non-small cell lung cancer[J]. Cancer Chemother Pharmacol, 20 10,66(3):449-53.
|
| [7] |
Kataoka K, Suzuki R, Taniguchi H, et al. Phase Ⅰ/Ⅱ trial of docetaxel and carboplatin as a fi rst-line therapy in patients with stage Ⅳ non-small-cell lung cancer[J]. Lung,2006,184(3):133-9.
|
| [8] |
Zhang P,Feng FY,Wu LY, et al. Phase Ⅱ multicenter clinical trial of nedaplatin in the treatment of malignant tumors[J]. Zhongguo Zhong Liu Za Zhi, 2006, 28(3):230-4.[张频,冯奉仪, 吴令英,等.奈达铂治疗恶性肿瘤的临床研究[J].中华肿瘤杂 志,2006,3(28):230-4.]
|
| [9] |
Schiller JH, Harrington D, Belani CP, et al. Comparison of four chemotherapy regimens for advanced non-small- cell lung cancer [ J] . N Engl J Med,2002,346(2):92-8.
|
| [10] |
Wang Q,Shan L. Clinical observation of the regimen for docetaxel combined with cisplatin and dedaplain chemotherapy in the treatment of advanced non-small cell lung cancer[J].Xin Jiang Yi Ke Da Xue Xue Bao,2009,32(7):901-3,905.[王强,单利.多西紫杉 醇联合顺铂与联合奈达铂化疗方案治疗晚期非小细胞肺癌的 临床观察[J].新疆医科大学学报,2009,32(7):901-3,905.]
|
| [11] |
Hanna N,Shepherd FA，Fossella FV, et al. Randomized phase Ⅲ trial of pemetrexed versus docetaxel in patients with nonsmall- cell lung cancer previously treated with chemotherapy[J]. J Clin Oncol,2004,22(9):1589-97.
|
| [12] |
Rodrigues-Pereira J, Kim JH, Magallanes M, et al. A randomized phase 3 trial comparing pemetrexed/carboplatin and docetaxel/ carboplatin as fi rst-line treatment for advanced, nonsquamous nonsmall cell lung cancer[J]. J Thorac Oncol,2011,6(11):1907-14.
|
下载:
